The Claims Supplement Marketing Should Stop Making

A case for precision, restraint, and a more honest vocabulary in supplement communication.

There are phrases in the supplement industry that I think we should simply retire.

Not because supplements are useless. Not because research is meaningless. And not because every manufacturer using these phrases is deliberately misleading people.

The problem is more subtle.

Certain expressions create far more certainty in the mind of the consumer than the evidence behind them actually deserves.

I think this damages the entire industry.

If we want supplementation to be taken seriously, we have to become much more disciplined about language.

“Scientifically proven”

This is perhaps the most abused phrase of all.

Science rarely “proves” something in the way advertising uses the word.

A study may show an effect under particular conditions. A body of evidence may support a conclusion with high confidence. Multiple replications may make an effect increasingly difficult to dismiss.

But even very strong scientific conclusions remain conditional on methods, populations, doses, outcomes and future evidence.

“Scientifically proven” often compresses all of that into two words.

Sometimes what it actually means is: one small study produced a statistically significant result.

Those are not equivalent statements.

I would prefer: supported by human evidence, moderate evidence suggests, or, when appropriate, strong human evidence supports.

Language should reflect certainty. Not manufacture it.

“Clinically proven”

This phrase deserves the same suspicion.

What exactly was clinically demonstrated? In whom? Compared with what? At what dose? For how long? Was the tested product identical to the product being sold? Was the measured outcome meaningful? Were twenty participants involved or two thousand?

A clinical study is not a magic stamp.

Poor studies can be performed in humans. Small studies can be clinically conducted.

A trial may be perfectly legitimate while still being far too limited to justify a broad marketing claim.

Whenever I see “clinically proven,” I want to see the trial immediately.

“Boosts brain function”

I genuinely dislike this phrase.

What is “brain function”? Attention? Working memory? Reaction time? Wakefulness? Executive function? Mood? Learning? Sleep-deprived performance?

A person can improve in one domain and show no meaningful difference in another.

The brain is not a single metric.

A responsible claim should identify the outcome.

For example: improved reaction time in a particular acute attention task.

That sounds less spectacular. It is also much more informative.

“Supports neurotransmitter production”

This is another phrase that frequently substitutes mechanism for outcome.

A compound may participate in the synthesis of a neurotransmitter. That does not automatically mean that taking more of it increases cognition, improves mood, enhances memory, or produces a meaningful functional benefit.

Human physiology is regulated.

More precursor does not always mean more useful output. And more biological output does not always mean better performance.

Mechanism matters. But mechanism is not the destination.

“Crosses the blood-brain barrier”

This is scientifically relevant. It is not a benefit.

Water reaches the brain. Many drugs reach the brain. Many compounds reach the brain without producing the effect a marketing department wants to imply.

The fact that a molecule enters the central nervous system may help establish biological plausibility.

Nothing more.

What happens after it gets there is the question that matters.

“Synergistic formula”

This expression is used extraordinarily loosely.

If two ingredients are placed in the same capsule, they are not automatically synergistic.

If a combination performs better than placebo, synergy has still not necessarily been demonstrated.

To establish that the combination produces something beyond its components, we need the appropriate comparison.

Ideally: A, B, A + B, and placebo.

Without that kind of design, “synergy” is often simply another word for: we decided to use these ingredients together.

There is nothing wrong with a formulation rationale. There is something wrong with presenting a rationale as demonstrated interaction.

“Backed by studies”

Which studies?

This phrase is technically easy to satisfy.

Almost any sufficiently popular ingredient has “studies.”

Animal studies. Cell studies. Observational studies. Tiny uncontrolled trials. Trials in populations completely unrelated to the consumer being targeted.

What matters is not whether studies exist. What matters is whether the right studies exist for the claim being made.

I would rather see: Three randomised controlled trials in healthy adults have evaluated this specific outcome.

That tells me something. “Backed by studies” tells me almost nothing.

“Natural means safe”

I wish this idea would disappear completely.

Nature is not a safety classification.

A substance can be natural and pharmacologically powerful. Natural compounds can interact with medications. They can cause adverse reactions. They can be inappropriate during pregnancy. They can affect blood pressure, clotting, liver enzymes or sedation.

“Natural” may describe origin. It does not describe risk.

“No side effects”

This is another phrase that should almost never appear.

Perhaps no serious adverse effects were observed in a particular study. That is not the same as proving that side effects do not exist.

Small trials are particularly poor at detecting rare adverse events. Short trials tell us relatively little about long-term use.

Safety language should be specific: well tolerated in the available short-term trials.

That is less dramatic. Again, it is also more honest.

“Works for everyone”

Biology rarely behaves that way.

Baseline status matters. Genetics matter. Diet matters. Sleep matters. Medication matters. Age matters.

Deficiency matters. Disease state matters.

Even an intervention with strong average effects will not produce the same response in every individual.

The average participant in a clinical trial is not a promise to the next person who opens a bottle.

“More is better”

Sometimes higher doses increase effect. Sometimes they do nothing. Sometimes they increase adverse effects. Sometimes the dose-response curve is non-linear.

I find dose escalation particularly problematic in supplement culture because large numbers create an impression of potency.

A formula containing more milligrams can look more serious even when the extra amount has little scientific justification.

The correct dose is not the largest amount that fits into the product.

It is the amount that best reflects evidence, safety and formulation logic.

“Doctor formulated”

Perhaps it was.

But this says nothing by itself about the quality of the evidence.

Credentials matter when they represent relevant expertise and actual involvement. They should not function as decorative authority.

I care much more about: What evidence was reviewed? What was rejected? What uncertainty remained?

Was negative evidence considered? Who challenged the final interpretation?

Authority should strengthen a methodology. It should not replace one.

What should replace these claims?

I do not think supplement marketing needs to become dull.

We can communicate complex science clearly. We can be confident where confidence is justified. We can tell compelling stories.

But we should stop treating uncertainty as a marketing defect.

Sometimes the strongest sentence a company can publish is:

We do not know yet.

Sometimes: The mechanism is compelling, but human evidence is limited.

Sometimes: The evidence is promising, but we do not consider the claim established.

And sometimes: We previously believed this claim was justified. We no longer do.

For me, this is not anti-marketing. It is better marketing.

Because there is already enough noise in supplementation. Enough certainty. Enough miracle language.

Enough biological diagrams used to turn hypotheses into promises.

I would rather MindHeaven become known for a different sentence:

Here is what the evidence shows. Here is what it does not show. And here is where we draw the line.

If that means making fewer claims, I am comfortable with that.

The claims we keep will be worth more.